Global Breast Biopsy Core Needle Market Growth 2023-2029

Global Breast Biopsy Core Needle Market Growth 2023-2029

The global Breast Biopsy Core Needle market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Breast Biopsy Core Needle is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Breast Biopsy Core Needle is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Breast Biopsy Core Needle is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Breast Biopsy Core Needle players cover Mammotome, Hologic, C.R Bard, BD, Stryker, Galini SRL, Medtronic, Surgaid Medical and GMT Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Breast Biopsy Core Needle Industry Forecast” looks at past sales and reviews total world Breast Biopsy Core Needle sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast Biopsy Core Needle sales for 2023 through 2029. With Breast Biopsy Core Needle sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Biopsy Core Needle industry.

This Insight Report provides a comprehensive analysis of the global Breast Biopsy Core Needle landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Biopsy Core Needle portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Breast Biopsy Core Needle market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Biopsy Core Needle and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Biopsy Core Needle.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Biopsy Core Needle market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Needle Based Biopsy
Surgical Biopsy

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mammotome
Hologic
C.R Bard
BD
Stryker
Galini SRL
Medtronic
Surgaid Medical
GMT Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Breast Biopsy Core Needle market?

What factors are driving Breast Biopsy Core Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Breast Biopsy Core Needle market opportunities vary by end market size?

How does Breast Biopsy Core Needle break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.